4.94
price up icon13.56%   0.59
after-market アフターアワーズ: 4.97 0.03 +0.61%
loading
前日終値:
$4.35
開ける:
$4.37
24時間の取引高:
6.65M
Relative Volume:
1.74
時価総額:
$664.80M
収益:
-
当期純損益:
$-217.44M
株価収益率:
-2.2765
EPS:
-2.17
ネットキャッシュフロー:
$-205.20M
1週間 パフォーマンス:
-7.32%
1か月 パフォーマンス:
-10.83%
6か月 パフォーマンス:
+185.55%
1年 パフォーマンス:
+27.32%
1日の値動き範囲:
Value
$4.31
$5.025
1週間の範囲:
Value
$4.31
$5.20
52週間の値動き範囲:
Value
$1.11
$6.94

Prime Medicine Inc Stock (PRME) Company Profile

Name
名前
Prime Medicine Inc
Name
セクター
Healthcare (1135)
Name
電話
617-465-0013
Name
住所
60 FIRST ST., CAMBRIDGE
Name
職員
214
Name
Twitter
Name
次回の収益日
2025-10-31
Name
最新のSEC提出書
Name
PRME's Discussions on Twitter

PRME を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PRME
Prime Medicine Inc
4.94 775.49M 0 -217.44M -205.20M -2.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Prime Medicine Inc Stock (PRME) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-27 ダウングレード Citigroup Buy → Neutral
2025-05-20 ダウングレード H.C. Wainwright Buy → Neutral
2025-05-20 ダウングレード JP Morgan Overweight → Neutral
2024-12-10 開始されました JMP Securities Mkt Outperform
2024-05-20 開始されました H.C. Wainwright Buy
2024-05-16 アップグレード Citigroup Neutral → Buy
2024-04-22 開始されました Chardan Capital Markets Buy
2024-04-08 開始されました TD Cowen Buy
2024-04-03 開始されました Wedbush Outperform
2024-01-16 ダウングレード Stifel Buy → Hold
2023-12-08 開始されました Citigroup Neutral
2023-10-09 開始されました BMO Capital Markets Outperform
2023-07-31 開始されました Guggenheim Buy
2023-04-18 開始されました Stifel Buy
2022-11-14 開始されました Goldman Neutral
2022-11-14 開始されました JP Morgan Overweight
2022-11-14 開始されました Jefferies Buy
2022-11-14 開始されました Morgan Stanley Equal-Weight
すべてを表示

Prime Medicine Inc (PRME) 最新ニュース

pulisher
Nov 02, 2025

How Prime Medicine Inc. stock performs in weak economyMarket Growth Report & Community Consensus Picks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Price momentum metrics for Prime Medicine Inc. explained2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Prime Medicine’s Price Target Revision Sparks Market Interest - StocksToTrade

Nov 02, 2025
pulisher
Nov 02, 2025

Prime Medicine Eyes Expansion with Strategic Partnerships and Investor Engagement - timothysykes.com

Nov 02, 2025
pulisher
Nov 02, 2025

Prime Medicine, Inc. (NYSE:PRME) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Prime Medicine’s Investor Activities and Upcoming Developments Boost Market Interest - StocksToTrade

Nov 01, 2025
pulisher
Nov 01, 2025

Prime Medicine Stock Poised for Strategic Growth With New Developments - timothysykes.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Prime Medicine Inc. stock outperform growth indexesWeekly Investment Report & Fast Entry Momentum Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Prime Medicine (NASDAQ:PRME) Shares Up 9.9%Time to Buy? - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Prime Medicine (NYSE:PRME) Trading 11.9% HigherWhat's Next? - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Sumitomo Mitsui Trust Group Inc. Has $3.94 Million Position in Prime Medicine, Inc. $PRME - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Momentum divergence signals in Prime Medicine Inc. chartJuly 2025 PostEarnings & Community Trade Idea Sharing Platform - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

How institutional ownership impacts Prime Medicine Inc. stock2025 Big Picture & Safe Capital Growth Tips - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

PRME Stock Surge: A Buying Opportunity? - StocksToTrade

Oct 31, 2025
pulisher
Oct 31, 2025

Institutional investors in Prime Medicine, Inc. (NASDAQ:PRME) see US$174m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Does Prime Medicine Inc. qualify in momentum factor screeningEarnings Beat & Weekly High Potential Stock Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Technical signs of recovery in Prime Medicine Inc.Market Trend Review & Weekly Hot Stock Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Combining price and volume data for Prime Medicine Inc.Portfolio Value Summary & Weekly Chart Analysis and Trade Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using economic indicators to assess Prime Medicine Inc. potentialWeekly Profit Report & AI Based Buy and Sell Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How Prime Medicine Inc. stock reacts to job market dataJuly 2025 Summary & High Conviction Buy Zone Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

IQ EQ FUND MANAGEMENT IRELAND Ltd Reduces Stock Holdings in Prime Medicine, Inc. $PRME - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 03:29:26 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Smart tools for monitoring Prime Medicine Inc.’s price actionJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why Prime Medicine Inc. stock appeals to analystsWeekly Trade Recap & Intraday High Probability Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Comparing Prime Medicine Inc. in custom built stock radarsMarket Performance Recap & Stock Portfolio Risk Management - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can Prime Medicine Inc. stock outperform in 2025 bull marketTrend Reversal & Daily Technical Forecast Reports - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Prime Medicine (NASDAQ: PRME) to file IND/CTA for PM577 in H1 2026 for Wilson’s Disease - Stock Titan

Oct 30, 2025
pulisher
Oct 29, 2025

News impact scoring models applied to Prime Medicine Inc.Weekly Trade Review & Real-Time Volume Analysis - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Prime Medicine Update Reveals Latest Trends in Healthcare Stocks - Kalkine Media

Oct 29, 2025
pulisher
Oct 29, 2025

Prime Medicine (NASDAQ:PRME) Trading Down 5.8%Here's Why - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Prime Medicine (NYSE:PRME) Stock Price Down 6.5%Here's Why - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Is Prime Medicine Inc. stock supported by strong fundamentals2025 Risk Factors & Daily Chart Pattern Signals - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Prime Medicine (NYSE:PRME) Shares Gap DownShould You Sell? - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Prime Medicine (NASDAQ:PRME) Shares Gap DownHere's What Happened - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Published on: 2025-10-28 06:42:01 - newser.com

Oct 28, 2025

Prime Medicine Inc (PRME) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
大文字化:     |  ボリューム (24 時間):